Researchers have reported that IGF2BP3 protein expression is correlated with thick and high-grade tumors and predicts poorer overall, melanoma-specific, recurrence-free, and distant metastasis-free survivals, especially in acral lentiginous melanoma [11,12,13], generating great expectations for its potential prognostic value. Here, IGF2BP3 is linked to melanoma.